• $198,856.00
    Market Cap
  • -92.07%
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.01
$0.01
$0.01
1-Year Range
$0.01
$0.14
$0.01
Latest Close$0.01
Change
-$0.00010 (-0.90%)
Volume100
Market Cap$198,856.00
Shares Outstanding17.9M
P/E (TTM)-2.71
Diluted EPS (TTM)-$0.004
Enterprise Value$494,197.00

Information as of 05/27/2026

Company Profile

$198,856.00
Market Cap
-$56,097.00
Net Income
Sector: Healthcare
Industry: Biotechnology
444 ? 5th Avenue SW, Calgary, AB, Canada, T2P 2T8
587 577 9261

First Person Ltd., through its subsidiaries, engages in the formulation and distribution of wholesale food grade functional mushrooms and cognitive performance products focusing on the mental performance and wellness markets in the United States. It focuses on the research and development of psilocybin mushrooms. The company is headquartered in Calgary, Canada.

Key Executives

  • Cory J. Rosenberg
  • Robert C. Kaelin
  • Chris Claussen

Current Ownership Distribution

  • Other17.3M (96.18%)
  • Insiders687,500 (3.82%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)